Search Orphan Drug Designations and Approvals
-
| Generic Name: | NP-CSIC002 |
|---|---|
| Date Designated: | 12/26/2017 |
| Orphan Designation: | Treatment of anterior ischemic optic neuropathy (AION) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Neurizon Pharma 15 Paul-Ehrlich-Straße Tübingen, Baden-Württemberg Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







